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ABSTRACT 
 
Severe haemorrhage leads to a reflex bradycardia and hypotension. This 
is thought to be protective, but is attenuated by both concomitant 
musculo-skeletal injury and exogenous morphine. The aim of this study 
was to determine whether the injury-induced attenuation of the response 
to severe haemorrhage could be blocked by naloxone. Male Wistar rats, 
terminally anaesthetised with alphadolone/alphaxalone (19-20 mg.kg
-1
 
I.V.) were randomly allocated to one of four groups; in Groups I and IV 
haemorrhage was simple (40% of estimated total blood volume (BV)) 
while in Groups II and III it was initiated 10 min after the onset of bilateral 
hindlimb ischaemia (a model of musculo-skeletal injury). Groups I and II 
received 20 L of 0.9% saline intracerebroventricularly (I.C.V.) 
immediately before haemorrhage, while Groups III and IV received 20 g 
of naloxone I.C.V., in the same volume. Group I; the bradycardia reached 
its peak after the loss of 32.80.3% BV (meanS.E.M.). Blood pressure did 
not fall significantly until the loss of 15.03.0% BV. The response in 
Group IV was not significantly different from Group I. By contrast the 
bradycardia was absent after similar blood losses in Groups II and III, 
while hypotension was attenuated. These results indicate that naloxone, 
at a dose known to be effective in blocking opioid receptors and 
preventing other aspects of the response to injury, does not prevent the 
injury-induced attenuation of the response to severe haemorrhage. Thus 
the attenuation of the response to blood loss by injury is unlikely to be 
mediated via the  opioid receptors. 
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Introduction 
 
The body’s response to a progressive simple haemorrhage (blood loss in the 
absence of major tissue damage) is biphasic (Barcroft et al., 1944; Kirkman et 
al., 1994; Ohnishi et al., 1997). During mild haemorrhage there is a reduction 
in pulse pressure which results in unloading of the baroreceptors leading to a 
reflex tachycardia, positive inotropic effect, increase in peripheral resistance 
(Kircheim, 1976), all contributing to the maintenance of mean arterial blood 
(MAP).  
 
As the haemorrhage progresses a second phase becomes apparent involving 
a bradycardia, a fall in peripheral resistance and a profound fall in blood 
pressure (Barcroft et al., 1944). Phase II of the response to simple 
haemorrhage is not due to a failure of the baroreflex as sensitivity is still high 
(Little et al., 1984) but due to the recruitment of a ‘depressor’ reflex. The 
bradycardia is mediated by activation of the vagus nerve, as this can be 
blocked with atropine in humans (Lewis, 1932; Barcroft et al., 1944) and 
experimental animals (Little et al., 1989). Inhibition of the sympathetic efferent 
nerve fibres to the vasculature mediate the fall in total peripheral resistance 
(Öberg & Thorén, 1973). The result of these two responses is a profound fall 
in blood pressure. The bradycardia is thought to be a protective mechanism to 
prevent high levels of cardiac work with insufficient coronary perfusion (Öberg 
& Thorén, 1972). However, this protective reflex is lost in the presence of 
concomitant musculo-skeletal injury (Little et al., 1989; Mackway-Jones et al., 
1999); the bradycardia is prevented and the onset of hypotension is delayed 
(Little et al., 1989).  
 
Phase II of the response to haemorrhage is also attenuated by exogenous 
opioid agents (e.g., morphine) acting on the µ-opioid receptors (Ohnishi et al., 
1997). The endogenous opioids are also known to be responsible for the 
injury-induced modulation of the vagal limb of the baroreflex (Wyatt et al., 
1995). During injury the sensitivity of the baroreflex is reduced, this effect of 
injury can be blocked by naloxone and -funaltrexamine (-FNA), both  
opioid receptor antagonists, indicating that injury must mediate its effect on the 
baroreflex via activation of endogenous opioid receptors. However, blocking 
the  opioid receptors with a  specific opioid antagonist (e.g. ICI-174 856) 
does not inhibit the reduction in baroreflex sensitivity during injury (Wyatt et al., 
1995) indicating further that this effect is mediated by specific activation of the 
 opioid receptors. 
 
The aim of this study is to determine whether the effect of injury on the 
response to haemorrhage can be prevented by naloxone, injected into the 
lateral cerebral ventricles. 
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Methods 
 
Ethical approval  
 
The experiments were approved by the local ethics committee of Durham 
University and were conducted in accordance with the Animals (Scientific 
Procedures) Act, 1986.  
 
The study was conducted on 20 male Wistar rats of the Harlan Orlac strain 
(body weight 233-260 g), kept on a 12 h light/dark cycle and fed on Beekay 
standard rat and mouse diet (B & K Universal Ltd, UK). 
 
Implantation of cerebral ventricular guide cannulae 
 
7-14 days prior to the study 20 rats (210-230 g body weight) were 
anaesthetised with sodium pentobarbitone (Sagatal, Rhone Merieux Ltd, UK; 
60 mg.kg
-1
 intraperitoneal; I.P.). When a surgical level of anaesthesia was 
attained, i.e. the absence of spontaneous movement and corneal and paw 
pinch reflexes, the rat was secured in a stereotaxic frame (stereotaxic frame 
model 900, Kopf, Succo International Ltd, UK) using atraumatic ear bars.  
 
An incision was made along the midline of the scalp to expose the skull. A 
burr-hole was drilled to reveal the dura which was pierced with a needle. In 
each rat a guide cannula (stainless steel 22G, length 11.5 mm) was placed so 
that its tip lay 1mm above the right lateral cerebral ventricle at the following co-
ordinates: AP -1; L -1.8; DV -2.5 (Pellegrino et al., 1979), where bregma was 
taken as AP and L zero, while the dura was taken as DV zero. The guide 
cannula was secured in place with two jeweller's screws inserted into the skull 
with dental cement (Simplex Rapid, Associated Dental Products Ltd, UK), and 
sealed using a stylet. 
 
The scalp was sutured and the animals treated prophylactically with the 
antibiotic oxytetracycline hydrochloride (Terramycin Q-50, Pfizer Ltd, UK; 30 
mg.kg
-1
 I.M.) injected into the left thigh muscle. The animals were allowed to 
recover from the anaesthetic and housed individually in cages with free access 
to food and water containing chlortetracycline hydrochloride (Aureomycin, 
Cyanamid, UK; 0.25% w/v). 
 
By the day of the study the body weights of the rats had increased to 233-260 
g. On the day of the study anaesthesia was induced in all the rats by inhalation 
of isoflurane (Abbott Laboratories Ltd UK; 3.5% in O2/N2O, FiO2 = 0.5) in an 
anaesthetising chamber (Fluorovac, UK). Once the animal was surgically 
anaesthetised they were transferred to the operating table and the isoflurane 
administered by mask and co-axial scavenging (Fluovac
TM
, International 
Market Supplies, UK). The percentage of isoflurane was adjusted to 2.5 – 3.5 
% (0.7 L O2.min
-1
) to maintain a surgical level of anaesthesia.  
 
Surgical preparation 
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In each rat a cannula (2FG, Portex Ltd, UK) was inserted into the ventral tail 
artery and advanced until its tip lay in the abdominal aorta. Arterial blood 
pressure was monitored via this cannula using a strain gauge manometer 
(Sensonor 840, SensoNor a.s., Norway). A lateral tail vein was cannulated 
(2FG, Portex Ltd, UK) for drug administration. All cannulae were initially filled 
with heparinised saline (5 IU.ml
-1
 in 0.9% saline) to prevent coagulation of the 
blood in or around the cannula. Body temperature was monitored using a 
rectal thermocouple (Medical precision thermometer; Allab Copenhagen DM 
852). The electrocardiogram was recorded using needle electrodes placed in 
the skin of the ventrum, and heart period measured from the 
electrocardiogram. All physiological variables were amplified and recorded 
using a computerised Data Acquisition System (MacLab 85, ADInstruments, 
UK). Body temperature was maintained at 37.7 ± 0.1 °C (mean ± S.E.M.) 
throughout the study using a thermally-insulated operating mat and a heating 
lamp. 
 
Experimental protocol 
 
Following the surgical preparation the isoflurane was discontinued and 
anaesthesia maintained with alphadolone/alphaxalone (Saffan, Pitman-Moore, 
UK, 19-21 mg.kg
-1
.h
-1
; I.V.) using a pump (Harvard 22, Harvard Apparatus Ltd, 
UK) while the animals breathed air. The anaesthesia was adjusted within the 
range 19-21 mg.kg
-1
.h
-1
 to maintain an experimental level of anaesthesia (mild 
withdrawal and a pressor response of approximately 10 mmHg to a noxious 
pinch of the foot) with supplemental doses of 0.1 ml alphadolone/alphaxalone 
I.V. if required. The rats were allowed to stabilise for 60 min, before being 
allocated randomly to one of four groups:  
 Group I; intracerebroventricular (I.C.V.) saline (20 μL), sham bilateral hindlimb 
ischaemia and haemorrhage 
 Group II; I.C.V. saline (20 μL), bilateral hindlimb ischaemia and haemorrhage  
 Group III; I.C.V. naloxone (20 μg.20 μL
-1
 saline), bilateral hindlimb ischaemia 
and haemorrhage 
 Group IV; I.C.V. naloxone (20 μg.20 μL
-1
 saline), sham bilateral hindlimb 
ischaemia and haemorrhage.  
The lower abdomen of the rats were checked for fullness of the bladder and 
emptied accordingly by applying light pressure to the area. Briefly, baseline 
(pre-injury or pre-sham injury) measurements of heart period and arterial blood 
pressure were made. Ten minutes before the onset of haemorrhage, bilateral 
hindlimb ischaemia (an established model of musculo-skeletal tissue injury 
(Redfern et al., 1984)) was induced in groups II and III by application of rubber 
band tourniquets. The tourniquets were kept in place for the remainder of the 
study. The animals were allowed to stabilise for 10 min before a control (pre-
haemorrhage) recording was made. The rats were then given heparin 
(Monoparin 0.1 ml intra-arterial (I.A.) of 5000 IU.ml
-1
, solution providing 
approximately 2000 IU.kg
-1
, CP Pharmaceuticals Limited, Wrexham) to 
prevent coagulation and blood samples taken for blood gas analysis. Following 
this, 20 L 0.9% saline (Groups I and II) or 20 g naloxone (Sigma Chemical 
Company, UK) in 20 L 0.9% saline (Groups III and IV) was administered into 
the lateral cerebral ventricles over 20 s via the guide cannula.  
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Deadspace saline was then aspirated from the arterial cannula. Arterial blood 
was withdrawn anaerobically from the ventral tail artery in aliquots of 0.5 ml, at 
an overall rate of 2% estimated total blood volume (TBV) per minute until 40% 
of the total blood volume had been withdrawn. Total blood volume was 
calculated as 6.06 ml.(100 g body weight)
-1
 (Elebute & Little, 1978; Ohnishi et 
al., 1997). Cardiovascular measurements were made after the withdrawal of 
each aliquot of blood, each blood sample subjected to blood gas analysis 
(ABL5, Radiometer, Denmark), and the cycle repeated until 40% of the total 
estimated blood volume had been withdrawn. Once the haemorrhage was 
complete further cardiovascular measurements were made at 100 s intervals 
for the following 10 min. At the end of the experiment, ink (20 L) was injected 
through the I.C.V. cannula over 20 s to confirm the correct positioning of the 
cannula into the cerebral ventricles. The animals were then killed with an 
overdose of sodium pentobarbitone (Sagatal, Rhone Merieux Ltd, UK) 
administered I.V. without regaining consciousness. None of the animals 
received fluid resuscitation following the blood loss.  
 
A post mortem was performed to assess whether any internal damage had 
occurred from the insertion of the I.A. cannula or the thermistor, and to assess 
the presence of any macroscopic lung pathology and the fullness of the 
bladder. The brain was removed and sectioned to determine the distribution of 
ink. Ink was found in the lateral, third and fourth ventricles in all animals.  
 
Calculations and statistical analysis 
 
MAP was calculated accurately using MacLab software. Data are presented as 
mean ± S.E.M. Statistical comparisons were made using a 2-way analysis of 
variance for repeated measures (SPSS/PC v4.01) unless indicated otherwise, 
and the degrees of freedom adjusted using the Greenhouse-Geisser 
correction to minimise the risk of type 1 error (Ludbrook, 1994). Comparisons 
of non-repeated measurements between groups (baseline values, body 
weights) were made using one-way analyses of variance followed, where 
appropriate, by a Tukey post-hoc test (SPSS/PC v4.01). In all cases P<0.05 
was considered statistically significant. 
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Results 
 
There were no significant differences between any of the groups in initial 
baseline values for heart period, MAP, body weight and temperature or arterial 
blood gases (Table 1). 
 
Effects of haemorrhage on saline treated animals 
 
A progressive simple haemorrhage in rats treated with I.C.V. saline, led to an 
initial fall in heart period of 165 ms (P=0.04, paired t-test) after a loss of 
16.40.2% blood volume (BV), from a pre-haemorrhage level of 1476 ms. 
Further haemorrhage then led to a progressive increase in heart period with a 
maximum increase of 427 ms after the loss of 32.80.3% BV (P=0.01, paired 
t-test). MAP was initially maintained constant at a level of 102.34.0 mmHg 
until the loss of 15.03.0% BV, after which further haemorrhage led to a 
progressive fall in MBP reaching a minimum value of 20.91.7 mmHg 
(P=0.001) after the loss of 39.80.4% BV (Figure 1, Group I). 
 
Arterial oxygen tension remained constant in Group I at 91.42.9 mmHg until a 
loss of 19.70.2% BV after which it increased progressively to a maximum 
value of 112.21.6 mmHg after a loss of 39.80.4% BV. Arterial carbon 
dioxide tension fell to 42.02.4 mmHg from a pre-haemorrhagic level of 
44.41.4 mmHg, after the loss of 39.80.4% BV. Arterial pH was maintained 
relatively constant throughout the haemorrhage with a minimum value of 
7.340.02 after the loss of 40.00.0% BV. Arterial base excess (ABE) initially 
rose to a maximum value of 3.350.48 mM after the loss of 13.10.12% BV. 
Thereafter it fell, reaching a minimum value of –2.51.2 mM at the end of the 
haemorrhage. 
 
Effects of injury on the response to haemorrhage in saline treated 
animals 
 
The response to haemorrhage in animals subjected to bilateral hindlimb 
ischaemia was different to that seen in animals without ischaemia. The 
bradycardia was blunted (P=0.02) and the fall in blood pressure delayed 
(Figure 1, Group II). Thus, rats treated with I.C.V. saline and subject to bilateral 
hindlimb ischaemia preceding the haemorrhage displayed a progressive 
significant fall in heart period from a lower initial pre-haemorrhagic level 
(compared to Group I) of 1324 ms to 1172 ms (P=0.03) after the loss of 
23.50.3% BV. Further haemorrhage then caused an increase in heart period 
reaching a maximum value of 1427 ms at the end of the haemorrhage, which 
was not different from pre-haemorrhage baseline (P=0.15). MAP showed a 
higher initial value of 121.74.3 mmHg, compared to Group I (P=0.01), which 
was maintained constant until the loss of 23.50.3% BV where, thereafter, it 
showed a progressive decrease reaching a minimum value of 27.13.3 mmHg 
(P=0.001) at end haemorrhage (Figure 1, Group II).  
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Arterial oxygen tension remained constant at 99.03.5 mmHg until a loss of 
23.50.3% BV were it slowly and progressively showed a significant increase, 
with a maximum value of 116.24.2 mmHg (P=0.01) after a loss of 40.00.0% 
BV (i.e. at the end of the haemorrhage). Arterial carbon dioxide tension fell 
from a pre-haemorrhagic level of 40.01.4 mmHg, to 37.41.6 mmHg at the 
end of the haemorrhage. Arterial pH was maintained relatively constant 
throughout the haemorrhage with a minimum value of 7.390.01 after the loss 
of 40.00.0% BV. Arterial base excess was not different from that in Group I. 
 
Effects of haemorrhage in naloxone treated animals 
 
Progressive simple haemorrhage in the absence of injury, in animals treated 
with I.C.V.  naloxone (Group IV) showed no significant differences in the 
changes in heart period, blood pressure and arterial blood gases from those 
seen during haemorrhage in animals treated with I.C.V. saline (i.e. Group I; 
Figure 1).  
 
 
Effects of I.C.V. naloxone on the response to haemorrhage and injury  
 
The change in heart period, MAP and arterial blood gases during 
haemorrhage and injury in naloxone treated rats (Group III) showed no 
difference from those in Group II treated with saline, haemorrhage and injury 
(Figure 1). Rats treated with I.C.V. naloxone and subjected to bilateral hindlimb 
ischaemia, showed no bradycardia and hypotension was delayed until 24% of 
the total blood volume was lost.  Therefore, with respect to the bradycardic 
response to haemorrhage, injury was shown to have a significant effect 
(P<0.001), while naloxone had no significant effect (P=0.190) and there was 
no significant interaction between these two factors (P=0.778), i.e. the effects 
of injury were unaffected by naloxone treatment. 
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Discussion 
 
The primary finding of this study is that naloxone, given into the cerebral 
ventricles, was did not modify the effects of bilateral hindlimb ischaemia on the 
response to haemorrhage. This suggests that the attenuation of the depressor 
response to blood loss by hindlimb ischaemia is not mediated by the  opioid 
receptors accessible to drugs injected into the lateral cerebral ventricles. This 
is in contrast to the effect of bilateral hindlimb ischaemia on the baroreflex, 
which can be blocked by naloxone given I.C.V.  (Wyatt et al., 1995; Little, 
1998). The results in Group I, show the biphasic pattern of cardiovascular 
response to a simple haemorrhage; the saline treated animals (Barcroft et al., 
1944; Kirkman et al., 1994; Ohnishi et al., 1997). The pattern of response of 
the blood gases is also consistent with that found in other studies (Ohnishi et 
al., 1997; Little, 1998) and is thought to be as a result of the stimulation of the 
arterial chemoreceptor reflex by the reduction in blood flow through, and a 
sympathetically-mediated vasoconstriction of the carotid and aortic bodies, as 
a consequence of a reduced blood volume during the haemorrhage (Acker & 
O'Regan, 1981). Thus, ventilation is stimulated causing the decrease in 
carbon dioxide tension and the increase in oxygen tension seen. 
 
The effects of the injury model, bilateral hindlimb ischaemia, on saline treated 
animals (Group II) during progressive haemorrhage was as expected (Little et 
al., 1989); a blockade of the bradycardia and attenuation of the hypotension 
seen during phase II of the response to a simple haemorrhage. Moreover, 
MAP was maintained until a significantly larger volume of blood had been lost; 
it did not begin to fall until after a loss of 23% blood volume compared to 15% 
blood volume in the haemorrhage and sham injury group. Heart rate and MAP 
were also higher during haemorrhage on a background of injury than with a 
similar volume during a simple haemorrhage. 
 
The opioid antagonist naloxone, when given into the cerebral ventricles, had 
no effect on the response to haemorrhage or its modification by injury. Animals 
in Group III, treated with naloxone and subjected to bilateral hindlimb 
ischaemia, showed no bradycardia and hypotension was delayed until 24% of 
the total blood volume was lost. This result shows the same pattern of 
response as rats treated with saline and subjected to the same injury model 
(Group II). The blood gas results also showed the same pattern of change 
throughout both experimental protocols. Animals in Groups I and IV, which 
were subjected to a progressive simple haemorrhage and treated with either 
saline or naloxone into the cerebral ventricles, showed an identical pattern of 
response to haemorrhage. This showed that naloxone itself had no effect on 
the response to a simple haemorrhage, and thus any change in the response 
to haemorrhage and injury would be certain to be as a result of the effect of 
naloxone on the response to injury. Thus, the results of this study would 
indicate that naloxone does not block the injury-induced modification of the 
response to haemorrhage utilising a pathway accessible via the I.C.V. route, 
unlike its effects on the injury-induced modification of the baroreflex (Wyatt et 
al., 1995; Little, 1998). However, naloxone may have an effect on the injury-
induced modification of the response to haemorrhage via pathways elsewhere 
in the brain, not accessible via the cerebral ventricles.  
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As I.C.V. administration of naloxone would only reach the periventricular areas 
future studies should investigate the effects of high dose intravenous or 
intracarotid naloxone (sufficient to block cerebral μ opioid receptors) on the 
injury-induced modification of the response to severe haemorrhage. 
Administration of a high dose of naloxone via these routes would enable the 
drug to reach more distant sites than adding it into the cerebral ventricles. The 
interpretation of results from these studies would however be difficult due to a 
possible peripheral site of action, but if the endogenous opioid system really is 
not involved in the injury-induced modification of the response to a severe 
haemorrhage, then naloxone would still have no effect.   
 
In contrast to this study, high doses of naloxone administered centrally have 
been shown to delay the decompensatory phase of the response to 
haemorrhage in conscious sheep (Frithiof & Rundgren, 2006; Frithiof et al., 
2007)  and rabbits (Evans et al., 1989). However, haemorrhage-induced 
bradycardia is much smaller in these species compared to rat (Ohnishi et al., 
1997) and man (Barcroft et al., 1944; Secher & Bie, 1985). In man during 
lower body negative pressure (LBNP), which reduces venous return (Little, 
1998; van Hoeyweghen et al., 2001), naloxone does not delay the onset of 
presyncope (Smith et al., 1993). Likewise, in anaesthetised rats, centrally 
administered naloxone failed to attenuate the bradycardia associated with 
severe blood loss (Little, 1998). However, systemically administered naloxone 
in conscious rats is effective in reversing the decompensatory phase of the 
response to haemorrhage via a cerebral mechanism (Faden & Holaday, 1979) 
as well as virtually abolishing it if used as pre-treatment intrathecally (Ang et 
al., 1999). However, the route of administration in this current study was 
different from these last two studies and hence the structures affected are 
likely to be very different. 
 
Naloxone has a higher binding affinity for the μ-opioid receptor subtype than 
for the δ-receptors (20-fold) and the κ-receptors (10-fold) (Goldstein & Naidu, 
1989). The high doses of naloxone administered in the aforementioned sheep 
studies (Frithiof & Rundgren, 2006; Frithiof et al., 2007)  are likely to delay the 
decompensatory phase of the response to haemorrhage by inhibition of both 
δ-  and κ-opioid receptor subtypes (Frithiof et al., 2007). However, in 
anaesthetised rats I.C.V. administration of  high doses of naloxone, which 
would antagonise the δ- as well as µ-opioid receptor subtypes, failed to 
attenuate the bradycardia associated with severe blood loss (Little, 1998). 
Indeed at doses high enough to antagonise μ-, δ- and κ-opioid receptors 
naloxone reduced tolerance to LBNP in healthy humans (Lightfoot et al., 
2000), and similar observations are seen following head-up tilt, (Madsen et al., 
1995), i.e. the decompensated phase was apparent sooner.  
 
 
In contrast to the effects of centrally administered naloxone in this study (see 
Figure 1) microinjections of the δ-receptor antagonist naltrindole into a more 
specific area of the brain; the caudal midline medulla (CMM) delayed the 
hypotension and attenuated the bradycardia associated with severe 
haemorrhage in anaesthetised rats (Henderson et al., 2002). However I.C.V. 
  
 - - 11 - -  
 
 
administration of the δ-receptor agonist DPDPE does not have an effect on 
the decompensatory phase of severe haemorrhage in the anaesthetised rat 
(Little, 1998). Further studies should now determine whether a δ-opioid 
receptor agonist, injected into a more specific area of the brain, such as the 
CMM, blocks the injury-induced modification of the response to a severe 
haemorrhage in the rat. 
 
Conclusions  
 
Exogenously administered naloxone given into the cerebral ventricles failed to 
prevent the injury-induced attenuation of the response to a severe progressive 
haemorrhage in the rat. But this does not mean that the endogenous opioid 
system is not involved in this modification, it simply means that the response is 
not mediated via direct activation of  opioid receptor subtypes accessible via 
the cerebral ventricles. The way forward may be to take a closer look at the 
involvement of the δ opioid receptor subtypes in this response. Administration 
of a δ opioid agonist into a specific area of the brain, perhaps the CMM, may 
prove to block the modification of the response to haemorrhage by injury. A 
better understanding of the relationship of the endogenous opioids with GABA 
within the central nervous system may shed more light on the mechanisms 
underlying this response and manipulation of this relationship may prove a 
means for restoration of the protective reflex for the heart during the response 
to trauma.  
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Figure 1. The effects of a progressive haemorrhage of 40% total blood volume (TBV) on heart period (HP) and 
mean arterial blood pressure (MBP) in anaesthetised rats.  
Group I; (▲) sham bilateral hindlimb ischaemia (BHLI), haemorrhage and intracerebroventricular (I.C.V.) 
administration of 20L saline, Group II; (■) BHLI, haemorrhage and 20L saline I.C.V., Group III; (♦) BHLI, 
haemorrhage and 20g naloxone per 20L saline I.C.V. and Group IV; (○) sham BHLI, haemorrhage and 20g 
naloxone per 20L saline I.C.V. Values are mean  S.E.M. 
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Table 1. Baseline values of all groups 
 Group I Group II Group III Group IV 
n 5 5 5 5 
Body wt (g) 2522 2463 2454 2453 
HP (ms) 1409 1456 1468 1499 
MBP (mmHg) 1093 993 1054 1009 
Pa,O2 (mmHg) 91.42.9 99.03.5 96.21.5 86.81.6 
Pa,CO2 (mmHg) 44.41.4 40.01.4 40.41.2 41.40.9 
apH 7.380.01 7.400.01 7.400.01 7.390.01 
ABE (mM) 1.00.4 0.40.8 0.20.9 0.51.0 
Hct (%) 39.01.5 37.02.0 38.70.4 37.40.7 
Temp (
o
C) 37.90.1 37.70.2 37.61.3 37.90.1 
Values are means  S.E.M. Abbreviations: n, number of rats; Body wt, body weight; HP, heart period; MBP, mean 
arterial blood pressure; Pa,O2, arterial oxygen tension; Pa,CO2, arterial carbon dioxide tension; apH, arterial pH; ABE, 
arterial base excess; Hct, haematocrit; Temp, body temperature.  
 
 
